These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7899374)

  • 1. [Autoimmune diabetes after treatment with interferon-alpha].
    Mathieu E; Fain O; Sitbon M; Thomas M
    Presse Med; 1995 Jan; 24(4):238. PubMed ID: 7899374
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin-dependent diabetes mellitus induced by interferon-alpha].
    Giuntoli P; Mariani S; Avoli D; Giammarco V
    Minerva Endocrinol; 1995 Dec; 20(4):243-5. PubMed ID: 8709922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and interferon-alpha therapy.
    Murakami M; Iriuchijima T; Mori M
    Ann Intern Med; 1995 Aug; 123(4):318. PubMed ID: 7611607
    [No Abstract]   [Full Text] [Related]  

  • 4. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
    Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R
    Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon-alpha and development of type 1 diabetes].
    Pinés Corrales PJ; Aragón Valera C; Sanchón Rodríguez R; Ugidos de la Varga L
    Med Clin (Barc); 2005 Sep; 125(7):278-9. PubMed ID: 16137490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
    Popescu C; Popescu GA; Arama V
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):101-4. PubMed ID: 23539399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.
    Yagyu H; Okada K; Sato S; Yamashita Y; Okada N; Osuga J; Nagasaka S; Sugano K; Ishibashi S
    Diabetes Res Clin Pract; 2012 Mar; 95(3):e52-4. PubMed ID: 22154462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Augmentation of the immune response to islet cell antigens with development of diabetes mellitus caused by interferon-alpha therapy in chronic hepatitis C].
    Seifarth C; Benninger J; Böhm BO; Wiest-Ladenburger U; Hahn EG; Hensen J
    Z Gastroenterol; 1999 Mar; 37(3):235-9. PubMed ID: 10234796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of chronic hepatitis C developing insulin-dependent diabetes, thyroid autoimmunity and stiff-person syndrome as complications of interferon therapy.
    Scavone G; Zaccardi F; Manto A; Caputo S; Pitocco D; Ghirlanda G
    Diabetes Res Clin Pract; 2010 Aug; 89(2):e36-8. PubMed ID: 20541278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
    Schories M; Peters T; Rasenack J; Reincke M
    Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alfa and development of type 1 diabetes mellitus.
    Koivisto VA
    Lancet; 1992 Nov; 340(8829):1236. PubMed ID: 1359316
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-alpha and development of type 1 diabetes: a case without insulin resistance.
    Tohda G; Oida K; Higashi S; Hayashi T; Miyamori I
    Diabetes Care; 1998 Oct; 21(10):1774. PubMed ID: 9773746
    [No Abstract]   [Full Text] [Related]  

  • 16. [[Insulin-dependent diabetes mellitus as a possible sequelae of treatment of viral hepatitis with interferon-alpha] ].
    Petrovicová A
    Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):158-61. PubMed ID: 11188763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse reactions of different treatments in chronic hepatitis C].
    Luca C; Grigore L; Vâţă A; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):991-5. PubMed ID: 20191864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of HCV infection with interferon alpha and ribavirin in a child with diabetes I type].
    Jasonek J; Kacprzak-Bergman I; Zaleska I
    Przegl Epidemiol; 2006; 60(2):259-63. PubMed ID: 16964677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha and its contribution to autoimmunity.
    Selmi C; Lleo A; Zuin M; Podda M; Rossaro L; Gershwin ME
    Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.
    Schreuder TC; Gelderblom HC; Weegink CJ; Hamann D; Reesink HW; Devries JH; Hoekstra JB; Jansen PL
    Liver Int; 2008 Jan; 28(1):39-46. PubMed ID: 18031478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.